poisar

Stocks · News reference

Rep. Rick Allen Has Sold Up to $50K Worth Of Rollins Stock: Here’s What You Should Know

Benzinga Insights

Records from September 22, 2026 indicate that Representative Rick Allen of Georgia made a sale of Rollins (NYSE:ROL), valued between $15,001 and $50,000, with the transaction dated August 12, 2026 and filed in

More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

ABTAVGOROL
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Researchandmarkets.Com

    Mexico Cardiac Rhythm Management Devices Market Outlook to 2036 Provides Revenue, Volume, Pricing and Competitive Insig

    ResearchAndMarkets.com released a comprehensive market report on Mexico's cardiac rhythm management devices sector, covering CRT, ICDs, and pacemakers through 2036. The report provides revenue forecasts, sales volume data, pricing analysis, and 2025 competitive positioning for major market players, supporting strategic decision-making for manufacturers, investors, and healthcare stakeholders.

    ABTMDTBSX
  2. Bcc Research

    Functional Foods and Beverages Market to Reach $591.7 Billion by 2030, Driven by Rising Consumer Demand for Preventive Health Nutrition

    The global functional foods and beverages market is projected to grow from $365.1 billion in 2024 to $591.7 billion by 2030, with a CAGR of 8.6%. Growth is driven by consumer shift toward preventive health nutrition, premiumization, beverage innovation, and expansion in Asia-Pacific. North America leads with 34.3% market share, while emerging technologies like microbiome science and AI-driven personalization reshape competition.

    NSRGYPEPKODANOYABT
  3. Delveinsight

    Global Alzheimer’s Disease Biomarker Market Poised for Phenomenal Expansion at a Growth Rate of ~9% by 2034 | DelveInsight

    The global Alzheimer's disease biomarker market is projected to grow from USD 2.2 billion in 2025 to USD 4.7 billion by 2034, driven by rising disease prevalence, aging populations, and advancements in blood-based biomarkers like phosphorylated tau and amyloid-beta assays. North America leads the market with 41% share, while Asia-Pacific is the fastest-growing region. Recent FDA clearances and expanded laboratory testing availability are accelerating market adoption.

    RHHBYQTRXABTTMOSMMNY
  4. Keithen Drury

    Here's My Top Low-Risk, High-Potential-Reward Stock That's Thriving in the Artificial Intelligence (AI) Boom

    Taiwan Semiconductor Manufacturing (TSMC) is positioned as a low-risk, high-reward AI investment due to its dominant 72.5% market share in chip fabrication and irreplaceable manufacturing capacity. With massive capital investments ($265 billion for Arizona facilities) and projected AI spending growth to $3-4 trillion by 2030, TSMC is well-positioned to benefit from AI demand regardless of which specific chip designers lead the market. The stock trades at reasonable valuations of 26x forward earnings.

    TSMNVDAAMDAVGO
  6. Will Healy

    Where Will Broadcom Stock Be in 5 Years?

    Broadcom stock has surged 7.5-fold over the past five years driven by AI chip demand and specialized semiconductor development. While future gains may not match this performance, the company's diversified portfolio—with hardware comprising 68% of revenue and infrastructure software 32%—positions it to outperform the market. The software segment serves as a hedge against chip industry cyclicality, though elevated valuation ratios (CAPE at 41) suggest potential AI market correction risks over the next five years.

    AVGO